Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#51 / 200 Total
HUT - Hut 8 Corp - Stock Price Chart
TickerHUT [NASD]
CompanyHut 8 Corp
CountryUSA
IndustryCapital Markets
Market Cap787.42MEPS (ttm)-2.75
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y9.00%
P/S13.79EPS next 5Y-
P/B2.12EPS Q/Q102.63%
Dividend-Sales Q/Q77.60%
Insider Own0.39%Inst Own17.77%
Insider Trans-35.11%Inst Trans-
Short Float6.93%EarningsMay 15/b
Analyst Recom2.00Target Price12.33
Avg Volume3.84M52W Range6.18 - 22.75
Hut 8 Corp. operates as a Bitcoin miner that focuses on mining. It provides digital asset mining, hosting, and managed infrastructure operation services. The company was founded on January 27, 2023 and is headquartered in Miami, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Visram ShenifChief Financial OfficerMay 09 '24Sale8.1517,905145,94030,865May 10 06:08 PM
Leverton JaimeChief Executive OfficerJan 12 '24Sale10.1035,761361,261269,415Jan 16 08:35 PM
Leverton JaimeChief Executive OfficerDec 22 '23Sale14.2198,7241,402,957238,509Dec 27 07:04 PM
Amdiss AnissChief Legal OfficerDec 22 '23Sale14.2118,513263,08623,333Dec 27 07:03 PM
Visram ShenifChief Financial OfficerDec 22 '23Sale14.1417,897253,06715,437Dec 27 07:04 PM
ABIO - ARCA biopharma Inc - Stock Price Chart
TickerABIO [NASD]
CompanyARCA biopharma Inc
CountryUSA
IndustryBiotechnology
Market Cap54.41MEPS (ttm)-0.42
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y48.59%
P/S-EPS next 5Y-
P/B1.55EPS Q/Q-48.29%
Dividend-Sales Q/Q-
Insider Own6.49%Inst Own81.63%
Insider Trans0.00%Inst Trans11.33%
Short Float30.26%EarningsApr 25/a
Analyst Recom1.00Target Price17.00
Avg Volume1.46M52W Range1.56 - 3.88
ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of targeted therapies for cardiovascular diseases. The firm focuses on the cardiovascular pathophysiology, molecular genetics, and clinical development. Its product candidate, Gencaro is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.
CABA - Cabaletta Bio Inc - Stock Price Chart
TickerCABA [NASD, RUT]
CompanyCabaletta Bio Inc
CountryUSA
IndustryBiotechnology
Market Cap592.96MEPS (ttm)-1.66
P/E-EPS this Y-16.47%
Forward P/E-EPS next Y-7.69%
PEG-EPS past 5Y-26.63%
P/S-EPS next 5Y-
P/B2.57EPS Q/Q11.80%
Dividend-Sales Q/Q-
Insider Own13.55%Inst Own94.42%
Insider Trans-0.52%Inst Trans-19.73%
Short Float25.33%EarningsMay 15/b
Analyst Recom1.00Target Price34.11
Avg Volume1.12M52W Range9.02 - 26.35
Cabaletta Bio, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in April 2017 and is headquartered in Philadelphia, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Binder GwendolynSee RemarksJan 19 '24Option Exercise1.0111,00011,11031,000Jan 19 06:30 PM
Binder GwendolynSee RemarksJan 19 '24Sale19.5911,000215,43920,000Jan 19 06:30 PM
Binder GwendolynSee RemarksDec 19 '23Option Exercise1.0111,00011,11031,000Dec 19 08:37 PM
Binder GwendolynSee RemarksDec 19 '23Sale21.8911,000240,78920,000Dec 19 08:37 PM
Binder GwendolynSee RemarksNov 20 '23Option Exercise1.0111,00011,11031,000Nov 21 04:30 PM
SCYX - Scynexis Inc - Stock Price Chart
TickerSCYX [NASD]
CompanyScynexis Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap83.88MEPS (ttm)1.86
P/E1.19EPS this Y-115.54%
Forward P/E25.82EPS next Y139.81%
PEG-EPS past 5Y-
P/S0.60EPS next 5Y-
P/B1.13EPS Q/Q101.20%
Dividend-Sales Q/Q21.50%
Insider Own5.25%Inst Own49.80%
Insider Trans0.00%Inst Trans-0.19%
Short Float2.73%EarningsMay 08/a
Analyst Recom1.00Target Price6.88
Avg Volume209.60K52W Range1.35 - 3.87
SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.
MMA - Alta Global Group Ltd. - Stock Price Chart
TickerMMA [AMEX]
CompanyAlta Global Group Ltd.
CountryAustralia
IndustryLeisure
Market Cap50.52MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float0.09%Earnings-
Analyst Recom-Target Price-
Avg Volume39.03K52W Range2.87 - 5.25
Alta Global Group Ltd. operates as a physical fitness center. It provides technology enabled combat fitness training to the everyday person both in gym and at home. The firms products include Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community. The company was founded by James Fleet, Nick Langton, John Kavanagh and Conor McGregor on March 27, 2013 and is headquartered in Sydney, Australia.
SMTI - Sanara MedTech Inc - Stock Price Chart
TickerSMTI [NASD, RUT]
CompanySanara MedTech Inc
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap289.63MEPS (ttm)-0.59
P/E-EPS this Y-51.92%
Forward P/E-EPS next Y86.08%
PEG-EPS past 5Y-
P/S4.26EPS next 5Y-
P/B6.69EPS Q/Q-45.39%
Dividend-Sales Q/Q19.42%
Insider Own60.07%Inst Own8.00%
Insider Trans0.00%Inst Trans27.38%
Short Float4.20%EarningsMay 13/b
Analyst Recom1.00Target Price44.00
Avg Volume13.60K52W Range26.06 - 46.40
Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.
DOUG - Douglas Elliman Inc - Stock Price Chart
TickerDOUG [NYSE, RUT]
CompanyDouglas Elliman Inc
CountryUSA
IndustryReal Estate Services
Market Cap115.19MEPS (ttm)-0.79
P/E-EPS this Y47.18%
Forward P/E7.41EPS next Y164.37%
PEG-EPS past 5Y-
P/S0.12EPS next 5Y-
P/B0.59EPS Q/Q-128.09%
Dividend-Sales Q/Q-6.27%
Insider Own22.34%Inst Own50.95%
Insider Trans0.10%Inst Trans-0.28%
Short Float4.25%EarningsMay 10/b
Analyst Recom2.00Target Price3.00
Avg Volume897.15K52W Range1.04 - 3.24
Douglas Elliman, Inc. is an independent residential real estate brokerage firm. It is engaged principally in two business segments: Real Estate Brokerage and Corporate & Other. The Real Estate Brokerage segment consists of residential real estate brokerage services through its subsidiary, Douglas Elliman Realty, which operates a residential brokerage company in the New York metropolitan area and also conducts residential real estate brokerage operations in Florida, California, Connecticut, Massachusetts, Colorado, New Jersey and Texas. The Corporate & Other segment consists of the operations of the holding company as well as its investment business that invests in select PropTech opportunities through its New Valley Ventures subsidiary. The company was founded by Douglas Elliman in 1911 and is headquartered in Miami, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LAMPEN RICHARDExecutive Vice President & COONov 21 '23Buy1.6910,00016,9461,621,097Nov 22 11:30 AM
LAMPEN RICHARDExecutive Vice President & COONov 16 '23Buy1.7410,00017,4331,611,097Nov 20 05:25 PM
KRAMER RONALD JDirectorAug 31 '23Buy2.5820,00051,60093,500Sep 05 04:15 PM
LAMPEN RICHARDExecutive Vice President & COOAug 22 '23Buy2.0950,000104,6401,601,097Aug 23 08:00 AM
LORBER HOWARD MChairman, President & CEOAug 21 '23Buy2.0750,000103,6904,248,619Aug 23 08:00 AM
JAN - JanOne Inc - Stock Price Chart
TickerJAN [NASD]
CompanyJanOne Inc
CountryUSA
IndustryBiotechnology
Market Cap30.03MEPS (ttm)-3.23
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y23.21%
P/S-EPS next 5Y-
P/B-EPS Q/Q80.97%
Dividend-Sales Q/Q-
Insider Own11.05%Inst Own2.26%
Insider Trans0.00%Inst Trans-7.54%
Short Float2.22%Earnings-
Analyst Recom-Target Price-
Avg Volume268.86K52W Range0.22 - 5.26
JanOne, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.
CRML - Critical Metals Corp. - Stock Price Chart
TickerCRML [NASD]
CompanyCritical Metals Corp.
CountryUSA
IndustryOther Industrial Metals & Mining
Market Cap85.18MEPS (ttm)-0.02
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B4.19EPS Q/Q-493.10%
Dividend-Sales Q/Q-
Insider Own17.67%Inst Own24.47%
Insider Trans0.00%Inst Trans-0.49%
Short Float1.10%Earnings-
Analyst Recom-Target Price-
Avg Volume51.21K52W Range5.32 - 22.50
Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns the Wolfsberg Lithium Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.
CPSS - Consumer Portfolio Service, Inc. - Stock Price Chart
TickerCPSS [NASD, RUT]
CompanyConsumer Portfolio Service, Inc.
CountryUSA
IndustryCredit Services
Market Cap180.45MEPS (ttm)1.44
P/E5.94EPS this Y-
Forward P/E-EPS next Y-
PEG0.30EPS past 5Y24.76%
P/S0.53EPS next 5Y20.00%
P/B0.65EPS Q/Q-65.72%
Dividend-Sales Q/Q4.39%
Insider Own60.09%Inst Own23.56%
Insider Trans-0.06%Inst Trans-3.35%
Short Float13.91%EarningsNov 09/a
Analyst Recom1.00Target Price8.00
Avg Volume24.57K52W Range7.30 - 13.74
Consumer Portfolio Services, Inc. operates as an independent finance company. The firm provides indirect automobile financing to individuals with past credit problems, low incomes, and limited credit histories. It engages in purchase and service of retail automobile contracts originated primarily by franchised automobile dealers and select independent dealers in the sale of new and used automobiles, light trucks, and passenger vans. The company was founded on March 8, 1991 and is headquartered in Las Vegas, NV.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WOOD DANIEL SDirectorDec 15 '23Sale9.268,00074,066220,067Dec 19 07:04 PM
Rayhill BrianDirectorOct 27 '23Option Exercise4.5370,000317,100222,181Oct 30 03:40 PM
WOOD DANIEL SDirectorOct 16 '23Option Exercise4.5320,00090,600237,958Oct 18 04:46 PM
123456789101120